262 results
Page 5 of 14
PRE 14A
pluczpmztu
11 Mar 19
Preliminary proxy
5:07pm
8-K
EX-99.1
jfd ocfd78h
7 Feb 19
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-99.1
hp37fcmtsx0s37
15 Jan 19
Entry into a Material Definitive Agreement
5:19pm
424B5
toj2xz
15 Jan 19
Prospectus supplement for primary offering
5:14pm
424B5
inx3gmcdumnzmtshx74
14 Jan 19
Prospectus supplement for primary offering
4:41pm
8-K
EX-99.1
uml81
7 Jan 19
Results of Operations and Financial Condition
8:11am
8-K
EX-99.1
kj8hsw7phrd
7 Nov 18
Alnylam Pharmaceuticals Reports Third Quarter 2018 Financial Results and Highlights Recent Period Activity
8:16am
8-K
EX-99.1
ww1htef6q12zc52jm6o
10 Aug 18
ONPATTROâ„¢ (patisiran) for the Treatment of the Polyneuropathy of Hereditary
3:45pm
8-K
EX-99.1
42fywak0qhxj0u4 rpr
2 Aug 18
Alnylam Pharmaceuticals Reports Second Quarter 2018 Financial Results and Highlights Recent Period Activity
8:15am
8-K
EX-99.1
z8mj62cpbeaum6 zav
3 May 18
Alnylam Pharmaceuticals Reports First Quarter 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-99.1
m2tb 2ik487
20 Apr 18
Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade
12:00am